|
See related Trental 400 CR tab information |
|
|
|
Manufacturer |
sanofi-aventis |
|
Distributor |
DKSH |
|
Contents |
Pentoxifylline |
|
Indications |
Treatment of peripheral occlusive arterial diseases & circulatory disorders of arteriosclerotic, diabetic, inflammatory or functional origin trophic disorders, lower leg ulcer & gangrene. Circulatory disorders of the eye, functional disorders of internal ears, cerebral blood flow disorders, ischaemic & post-apoplectic states.
Click to view Trental 400 detailed prescribing infomation |
|
Dosage |
Initially 1 tab tid. Maintenance: 1 tab bid.
Click to view Trental 400 detailed prescribing infomation |
|
Administration |
Should be taken with food (Take after meals. Swallow whole, do not chew/crush.). |
|
Contraindications |
Severe cerebral hemorrhage; recent MI; massive retinal hemorrhage. Pregnancy.
Click to view Trental 400 detailed prescribing infomation |
|
Adverse Drug Reactions |
GI upset; headache, flushing, tachycardia, angina pectoris or hypotension.
View ADR Monitoring Form |
|
Side Effects |
View Trental 400 side effects |
|
Drug Interactions |
May potentiate effects of antihypertensives. High parenteral dose may intensify hypoglycemic action of insulin & oral hypoglycemics.
View more drug interactions with Trental 400 |
|
Pregnancy Category (US FDA) |
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. |
|
Mechanism of Action |
View Trental 400 mechanism of action for pharmacodynamics and pharmacokinetics details. |
|
Presentation/Packing |
|
Form |
Packing |
Photo |
|
Trental 400 controlled-release tablet |
|
Trental 400 400 mg x 100's |
 |
|
|
|
Manufacturer: |
sanofi-aventis |
|
Distributor: |
DKSH
|
|
|
|
